The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Blood-Brain Barrier: Penetration of Morphine, Codeine, Heroin, and Methadone after Carotid Injection
Abstract
Labeled morphine, codeine, heroin, or methadone was injected as a bolus into the common carotid artery of the rat, and the rat was decapitated 15 seconds later. The brain uptake of the drug was calculated by measurement of the brain content of the drug as a percentage of a labeled, highly diffusible reference substance simultaneously injected. The uptake of morphine was below measurability; the uptake of codeine was 24 percent; heroin, 68 percent; and methadone, 42 percent. Brain uptakes of morphine and codeine were also studied after intravenous injection and correlated well with uptakes after carotid injection; the uptake of codeine being nearly complete by 30 seconds. These studies indicate that brain uptake of certain of these drugs is very rapid and that uptake of heroin injected intravenously is probably limited by the regional flow of blood in the brain. The possible relation of this rapid penetration of the blood-brain barrier by heroin to its strongly addictive properties is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
Oldendorf, W. (1971) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1971.221.6.1629 · Cited by 1,683
Self-citationRegional Blood Flow by Fractional Distribution of Indicators
Sapirstein, L. A. (1958) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1958.193.1.161 · Cited by 833
Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard
Oldendorf, W. H. (1970) · Brain Research · doi:10.1016/0006-8993(70)90123-x · Cited by 548
Self-citationMethadone Binding to Human Plasma Albumin
Olsen, G. D. (1972) · Science · doi:10.1126/science.176.4034.525 · Cited by 47
Cited by
Drug Transport across the Blood–Brain Barrier
Pardridge, W. M. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.126 · Cited by 1,994
Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 849
Understanding polydrug use: review of heroin and cocaine co‐use
Leri, F., Bruneau, J., & Stewart, J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00236.x · Cited by 790
Blood-brain barrier drug targeting: the future of brain drug development.
Pardridge, W. M. (2003) · Molecular Interventions · doi:10.1124/mi.3.2.90 · Cited by 570
Aryal, M., Arvanitis, C. D., Alexander, P. M., & McDannold, N. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.01.008 · Cited by 443
The role of reward pathways in the development of drug dependence
Wise, R. A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90108-2 · Cited by 432
Sporer, K. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00019 · Cited by 342
Conditioned taste aversion induced by self-administered drugs: Paradox revisited
Hunt, T., & Amit, Z. (1987) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(87)80005-2 · Cited by 334
Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system
Spyraki, C., Fibiger, H. C., & Phillips, A. G. (1983) · Psychopharmacology · doi:10.1007/bf00427827 · Cited by 307
Schuller, A. G. P., King, M. A., Zhang, J., Bolan, E., Pan, Y., Morgan, D. J., Chang, A., Czick, M. E., Unterwald, E. M., Pasternak, G. W., et al. (1999) · Nature Neuroscience · doi:10.1038/5706 · Cited by 307
In Vitro Blood–Brain Barrier Models: Current and Perspective Technologies
Naik, P., & Cucullo, L. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23022 · Cited by 288
Transport of small molecules through the blood-brain barrier: biology and methodology
Pardridge, W. M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00003-p · Cited by 279
Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier
Mikitsh, J. L., & Chacko, A.-M. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13384 · Cited by 271
Peptides and the blood–brain barrier
Banks, W. A. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.010 · Cited by 266
Eckhardt, K., Li, S., Ammon, S., Schänzle, G., Mikus, G., & Eichelbaum, M. (1998) · Pain · doi:10.1016/s0304-3959(98)00021-9 · Cited by 258
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01922 · Cited by 102
Enhancing autophagy in Alzheimer's disease through drug repositioning
Eshraghi, M., Ahmadi, M., Afshar, S., Lorzadeh, S., Adlimoghaddam, A., Rezvani Jalal, N., West, R., Dastghaib, S., Igder, S., Torshizi, S. R. N., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108171 · Cited by 89
Saito, Y., Buciak, J., Yang, J., & Pardridge, W. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10227 · Cited by 81
Evolving new-age strategies to transport therapeutics across the blood-brain-barrier
Choudhari, M., Hejmady, S., Narayan Saha, R., Damle, S., Singhvi, G., Alexander, A., Kesharwani, P., & Kumar Dubey, S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120351 · Cited by 74
Noble, F., & Marie, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00742 · Cited by 56
Metadata
- Authors
- Oldendorf, W. H., Hyman, S., Braun, L., & Oldendorf, S. Z.
- Venue
- Science
- Published
- 1972-12
- Volume
- 178
- Issue
- 4064
- Pages
- 984-986
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051188685
- Cited by
- 362
- References
- 4
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.